Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

RD14-01

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Nanjing Bioheng Biotech

Drug class:

ROR1-targeted CAR-T immunotherapy

Related drugs:

‹

›